+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
FEMALE
ID06450873

Phase 2 Study of Turkey Tail Mushrooms in Post-Menopausal Women with HER2-Negative ER-Positive Breast Cancer Undergoing Surgery

Led by Mayo Clinic · Updated on 2026-10-16

40

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of turkey tail mushroom TTM, a dietary supplement, in treating post-menopausal women with HER2-negative, estrogen receptor-positive breast cancer who are planning to undergo surgery. This phase II study aims to observe changes in tumor cell proliferation and assess the safety and impact of TTM on quality of life, mood, and energy levels. The trial explores TTMs potential as a treatment option during the window before surgery. Participants will take TTM orally twice daily starting from registration up to the day before their planned surgery, for a period ranging from 20 to 42 days, unless disease progression or unacceptable side effects occur. After completing the treatment period, participants will be followed up between 7 and 30 days after their last dose to monitor outcomes and any adverse effects. During the study, participants will undergo assessments including measurement of tumor proliferation marker Ki-67 at baseline and surgery, quality of life questionnaires, and monitoring for any side effects. Researchers will also collect patient-reported outcomes related to mood and energy levels. Overall participation includes the treatment period and the follow-up, lasting up to about 10 weeks in total.

CONDITIONS

Brief Title

Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery

Research Team

C

Clinical Trials Referral Office

C

Cancer Center Clinical Trials

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here